These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8213896)

  • 41. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives.
    Lövqvist A; Emanuelsson H; Nilsson J; Lundqvist H; Carlsson J
    J Intern Med; 1993 Mar; 233(3):215-26. PubMed ID: 8450289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restenosis after percutaneous transluminal coronary angioplasty.
    Pedersen HK; Vatne K; Simonsen S
    Acta Radiol; 1992 Mar; 33(2):149-51. PubMed ID: 1562409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of repeat angiography up to eight years following percutaneous transluminal angioplasty.
    Kober G; Vallbracht C; Kadel C; Kaltenbach M
    Eur Heart J; 1989 Dec; 10 Suppl G():49-53. PubMed ID: 2627949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Restenosis after coronary angioplasty: status in 1994].
    Vojácek J
    Vnitr Lek; 1995 May; 41(5):325-31. PubMed ID: 7653063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
    J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The urge to prevent restenosis after percutaneous transluminal coronary angioplasty. Scylla and Charybdis in disguise.
    Becker AE
    Circulation; 1992 Apr; 85(4):1632-3. PubMed ID: 1313345
    [No Abstract]   [Full Text] [Related]  

  • 50. Restenosis after percutaneous transluminal coronary angioplasty--anatomic and pathophysiological mechanisms. Strategies for prevention.
    Block PC
    Circulation; 1990 Mar; 81(3 Suppl):IV2-4. PubMed ID: 2407372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting late restenosis after coronary angioplasty by very early (12 to 24 h) thallium-201 scintigraphy: implications with regard to mechanisms of late coronary restenosis.
    Hardoff R; Shefer A; Gips S; Merdler A; Flugelman MY; Halon DA; Lewis BS
    J Am Coll Cardiol; 1990 Jun; 15(7):1486-92. PubMed ID: 2345228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty.
    Ip JH; Fuster V; Israel D; Badimon L; Badimon J; Chesebro JH
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):77B-88B. PubMed ID: 2016486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of magnesium on restenosis after percutaneous transluminal coronary angioplasty: a clinical and angiographic evaluation in a randomized patient population. A pilot study. The Ichilov Magnesium Study Group.
    Roth A; Eshchar Y; Keren G; Kerbel S; Harsat A; Villa Y; Laniado S; Miller HI
    Eur Heart J; 1994 Sep; 15(9):1164-73. PubMed ID: 7982415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
    J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive factors of restenosis after multivessel percutaneous transluminal coronary angioplasty.
    Le Feuvre C; Bonan R; Lespérance J; Gosselin G; Joyal M; Crépeau J
    Am J Cardiol; 1994 May; 73(12):840-4. PubMed ID: 8184804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increase in the delta ST/delta heart rate (HR) index: a new predictor of restenosis after successful percutaneous transluminal coronary angioplasty.
    Hamasaki S; Arima S; Tahara M; Kihara K; Shono H; Nakao S; Tanaka H
    Am J Cardiol; 1996 Nov; 78(9):990-5. PubMed ID: 8916476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restenosis after multilesion percutaneous transluminal coronary angioplasty.
    Vandormael MG; Deligonul U; Kern MJ; Kennedy H; Galan K; Chaitman B
    Am J Cardiol; 1987 Jul; 60(3):44B-47B. PubMed ID: 2956841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Restenosis, the Achilles heel of coronary angioplasty].
    Macaya C
    An Med Interna; 1991 Jan; 8(1):1-3. PubMed ID: 1912149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.